Correction to: Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey - Anne Brédart; Jean-Luc Kop; Antonis C. Antoniou; Alex P. Cunningham; Antoine De Pauw; Marc Tischkowitz; Hans Ehrencrona; Marjanka K. Schmidt; Sylvie Dolbeault; Kerstin Rhiem; Douglas F. Easton; Peter Devilee; et al. (Journal of Community Genetics, 2019)

A response to “Personalised medicine and population health: breast and ovarian cancer” - Antonis Antoniou; Hoda Anton-Culver; Alexander Borowsky; Mireille Broeders; Jennifer Brooks; Anna Chiarelli; Jocelyne Chiquette; Jack Cuzick; Suzette Delaloge; Peter Devilee; Michael Dorval; Douglas Easton; et al. (Human Genetics, 2019)

Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey - Anne Brédart; Jean-Luc Kop; Antonis C. Antoniou; Alex P. Cunningham; Antoine De Pauw; Marc Tischkowitz; Hans Ehrencrona; Marjanka K. Schmidt; Sylvie Dolbeault; Kerstin Rhiem; Douglas F. Easton; Peter Devilee; et al. (Journal of Community Genetics, 2019)

Corrections to: Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries - Anne Brédart; Jean‑Luc Kop; Antonis C. Antoniou; Alex P. Cunningham; Antoine De Pauw; Marc Tischkowitz; Hans Ehrencrona; Sylvie Dolbeault; Léonore Robieux; Kerstin Rhiem; Douglas F. Easton; Peter Devilee; et al. (Familial Cancer, 2018)

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries - Anne Brédart; Jean-Luc Kop; Antonis C. Antoniou; Alex P. Cunningham; Antoine De Pauw; Marc Tischkowitz; Hans Ehrencrona; Sylvie Dolbeault; Léonore Robieux; Kerstin Rhiem; Douglas F. Easton; Peter Devilee; et al. (Familial Cancer, 2018)

High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations - Astrid A. Out; Ivonne J. H. M. van Minderhout; Nienke van der Stoep; Lysette S. R. van Bommel; Irma Kluijt; Cora Aalfs; Marsha Voorendt; Rolf H. A. M. Vossen; Maartje Nielsen; Hans F. A. Vasen; Hans Morreau; Peter Devilee; et al. (Familial Cancer, 2015)

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers - Kate M. Im; Tomas Kirchhoff; Xianshu Wang; Todd Green; Clement Y. Chow; Joseph Vijai; Joshua Korn; Mia M. Gaudet; Zachary Fredericksen; V. Shane Pankratz; Candace Guiducci; Andrew Crenshaw; et al. (Human Genetics, 2011)

Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia - Anna P. Sokolenko; Maxim E. Rozanov; Natalia V. Mitiushkina; Natalia Yu. Sherina; Aglaya G. Iyevleva; Elena V. Chekmariova; Konstantin G. Buslov; Evgeny S. Shilov; Alexandr V. Togo; Elena M. Bit-Sava; Dmitry A. Voskresenskiy; Oleg L. Chagunava; et al. (Familial Cancer, 2007)

Repositioning the hereditary paraganglioma critical region on chromosome band 11q23 - B. E. Baysal; E. M. van Schothorst; Joan E. Farr; P. Grashof; David Myssiorek; Wendy S. Rubinstein; Peter Taschner; Cees J. Cornelisse; B. Devlin; Peter Devilee; C. W. Richard III. (Human Genetics, 1999)